Sildenafil citrate for the management of asymmetrical intrauterine growth restriction and its effect on umbilical artery Doppler
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20220550Keywords:
Fetal growth restriction, Small for gestational age, Umbilical artery Doppler, Sildenafil citrate managementAbstract
Background: Asymmetrical intrauterine growth restriction IUGR occurs when there is uteroplacental insufficiency. Sildenafil citrate phosphodiasterase-5 inhibito is a potent vasodilator, which selectively inhibits phosphodiesterase-5 and, as a consequence, enhances the action of cyclic guanosine monophosphate which is the second messenger of NO. Hence, the trial was used for improving uteroplacental perfusion through enhancing vasodilatation of myometrial small arteries boosting flow within uteroplacental bed. The aim was to evaluate the efficacy of adding sildenafil citrate to low dose aspirin in treatment of asymmetrical IUGR through its effect on uteroplacental blood flow guided by Doppler ultrasound.
Methods: Our study was a prospective double-blinded, randomized, controlled trial. Recruitment of participating women was from the obstetric outpatient clinic of Aswan university hospital. 100 patients included in the study and randomized in two groups. The first group was 50 patients assigned sildenafil with low dose aspirin and the second group was 50 patients assigned placebo with low dose aspirin.
Results: As regard the outcomes, the study demonstrated that using of SC and LDA were effective in increasing estimated fetal weight and in improvement of umbilical artery umbilical artery Doppler (UAD) indices RI and PI for pregnancy complicated with IUGR compared with the control group.
Conclusions: Sildenafil citrate is a promising treatment for IUGR fetuses with prolongation of pregnancy and improvement of fetal birth weight, umblical Doppler indices UDI, decreases days needed in PCU.
References
American College of Obstetricians and Gynecologists (ACOG) Practice bulletin no. 134: fetal growth restriction. Obstet Gynecol. 2013;121(5):1122-33.
Srinivas SK, Edlow AG, Neff PM, Sammel MD, Andrela CM, Elovitz MA. Rethinking IUGR in preeclampsia: dependent or independent of maternal hypertension. J Perinatol. 2009;29(10):680.
Downing JW, Ramasubramanian R, Johnson RF, Minzter BH, Paschall RL, Sundell HW, et al. Selective phosphodiesterase-5 inhibition improves outcome in preeclampsia. Med Hypotheses. 2012;63(6):1057-64.
Florio P, Marinoni E, DiIorio R, Bashir M, Ciotti S. Urinary S100B protein concentrations are increased in intrauterine growth-retarded newborns. Pediatrics. 2009;118:747-54.
Gardosi J, Madurasinghe V, Williams M, Malik A, Francis A. Maternal and fetal risk factors for stillbirth: population based study. BMJ. 2013;346:108.
Turan OM, Turan S, Berg C, Gembruch U, Nicolaides KH, Harman CR, et al. Duration of persistent Abnormal ductus venosus flow and its impact on perinatal outcome in fetal growth restriction. Ultrasound Obstet Gynecol. 2011;38(3):295-302.
Royal collage of obstetrician and gynecologists (ROCG). Small for gestational age fetus, investigation and management (green top guidelines 31). 2014.
Militello M, Pappalardo EM, Ermito S, Dinatale A, Cavaliere A, Carrara S. Obstetric management of IUGR. J Prenat Med. 2009;3(1):6.
Panda S, Das A, Nowroz HM. Sildenafil citrate in fetal growth restriction. J Reprod Infertil. 2014;15(3):168-9.
El-Sayed MA, Saleh SA, Maher MA, Khidre AM. Utero-placental perfusion Doppler indices in growth restricted fetuses: effect of sildenafil citrate. J Matern Fetal Neonatal Med. 2018;31(8):1045.
Ferreira E, Léveillée D, Iglesias MH, Brochet MS. Sildenafil use during pregnancy for intrauterine growth restriction. a case series. J Obstet Gynaecol Canada. 2016;38(5):486.
Singh A, Daharwal A, Kujur, Awasthi P. Effect of sildenafil on IUGR. Int J Reproduct Contracept Obstetr Gynecol. 2017;6(5):1806.
Dadelszen P, Dwinnell S, Magee LA, Carleton BC, Gruslin A, Lee B, et al. Sildenafil citrate therapy for severe early-onset intrauterine growth restriction. BJOG. 2011;118(5):624-8.
Lin TH, Su YN, Shih JC, Hsu HC, Lee CN. Resolution of high uterine artery pulsatility index and notching following sildenafil citrate treatment in a growth-restricted pregnancy. Ultrasound Obstet Gynecol. 2012;40(5):609-10.
Wareing M, Myers JE, O'Hara M, Baker PN. Sildenafil citrate (Viagra) enhances vasodilatation in fetal growth restriction. J Clin Endocrinol Metab. 2005;90(5):2550-5.
